M&G PLC Amicus Therapeutics, Inc. Transaction History
M&G PLC
- $16.6 Billion
- Q2 2025
A detailed history of M&G PLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, M&G PLC holds 1,884,985 shares of FOLD stock, worth $15.6 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,884,985Holding current value
$15.6 Million% of portfolio
0.07%Shares
3 transactions
Others Institutions Holding FOLD
# of Institutions
302Shares Held
331MCall Options Held
396KPut Options Held
249K-
Vanguard Group Inc Valley Forge, PA29.4MShares$243 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA29.1MShares$241 Million0.03% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$201 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY18MShares$149 Million1.88% of portfolio
-
William Blair Investment Management, LLC Chicago, IL14.6MShares$121 Million0.24% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.32B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...